The effects of peptidoglycan, a pyrogenic constituent of gram-positive microorganisms, on the pharmacokinetics of rifampicin
✍ Scribed by J. Lavický; Z. Urbanová; H. Rašková; J. Rotta; J. Vaněček
- Book ID
- 119007218
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 412 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0041-0101
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background and Objectives Lenvatinib is an oral, multitargeted tyrosine kinase inhibitor under clinical investigation in solid tumours. This study evaluated the influence of P-glycoprotein (P-gp) inhibition (single-dose rifampicin) and simultaneous cytochrome P450 3A4 (CYP3A4)/P-gp induction (mu
Tuberculosis chemotherapy involves combination of the drugs isoniazid (INH), rifampicin (RMP) and pyrazinamide (PYR) for a 6-month period. The present work investigated the influence of RMP and PYR on the pharmacokinetic parameters of INH when groups of rats were pre-treated for 21 days with INH alo